Also known as

Lutrin

Lutrin is a brand name for human chorionic gonadotropin, a hormone often used to support testicular function. This shop carries one product under this alias: Magnyl 1/1000IU Gonadatropin – Magnus. It is positioned within the HGH & Peptides category and is typically referenced for post-cycle therapy. The product is available in multiple EU languages, and its specific dosing and usage should be directed by a qualified healthcare professional.

All Products →

Understanding Lutrin

Lutrin refers to human chorionic gonadotropin, a glycoprotein hormone that plays a key role in reproductive physiology. It is structurally similar to luteinizing hormone and acts on the same receptor, thereby stimulating Leydig cells to produce testosterone. The product listed here is an injectable formulation with a strength of 1000 IU per unit. Users should be aware that it can cause fluid retention and may increase the risk of thrombotic events at higher doses.

Product and Usage

The only product sold under this alias is Magnyl 1/1000IU Gonadatropin – Magnus. It is manufactured by Magnus and is part of the HGH & Peptides category. This shop ships to EU countries only; it does not serve the US market. The site is available in seven languages, including English, German, Spanish, Italian, French, Polish, and Dutch. Buyers should consider these factors when selecting their source for human chorionic gonadotropin.

Questions & answers

What is the primary use of Lutrin?

Lutrin is used to support testicular function and is typically referenced for post-cycle therapy. It acts as a luteinizing hormone analog, stimulating testosterone production.

How is Magnyl 1/1000IU Gonadatropin dosed?

The product is an injectable formulation with a strength of 1000 IU per unit. Dosing should be determined by a qualified healthcare professional based on individual patient needs.

What are the potential side effects?

Commonly cited side effects include fluid retention and an increased risk of thrombotic events, particularly at higher doses. These risks should be monitored in clinical settings.